Our news

  • 19 April 2017

    NovaMedica launched Technology Center to develop innovative drugs

    NovaMedica launched Technology Center to develop innovative drugs

    NovaMedica, a Russian pharmaceutical company (RUSNANO portfolio company), started operation of the Technology Center designed for the development and pilot production of innovative drug products. It comprises a complex of R&D laboratories and production areas with technological capabilities which are unique for the Russian pharmaceutical industry and one of the best in Europe. Crucial tasks of the Technology Center are to develop the advanced oral medical products of different pharmacotherapeutic groups, including those to treat cardiovascular and gastroenterological diseases, central nervous system diseases, and to create painkillers drugs of the new generation.  

  • 23 December 2016

    Pfizer and NovaMedica Complete Strategic Partnership Agreement for the Technology Transfer of 30 Key Medicines

    Pfizer and NovaMedica Complete Strategic Partnership Agreement for the Technology Transfer of 30 Key Medicines

    Pfizer Inc, one of the world’s premier biopharmaceutical companies and NovaMedica, a Russian pharmaceutical company established by Rusnano and Domain Associates, have completed the last stage of negotiations for a long-term strategic partnership designed to transfer the rights and technologies for the production of more than 30 life-saving and essential drugs from the Pfizer product portfolio. The deal will enable Pfizer and NovaMedica to improve the health of patients in Russia and modernize the Russian pharmaceutical industry.

  • 19 December 2016

    The Expert Opinion. Maxim Gorbachev: "2016 Was a Good Year for Our Venture Biotech Portfolio - 2 IPO and 2 Acquisitions"

    The Expert Opinion. Maxim Gorbachev: "2016 Was a Good Year for Our Venture Biotech Portfolio - 2 IPO and 2 Acquisitions"

    Maxim Gorbachev, Managing Partner: "It’s right time to make the first results of 2016. Let’s have a quick look back on venture biotech market in 2016. How 2016 was for RMI Partners? On the contrary, we have a good year. Two of our portfolio companies have made IPO despite unfavorable market conditions and two - have been acquired at pretty nice valuations."

  • 10 November 2016

    NovaMedica prepares to launch the new drug development laboratories

    NovaMedica prepares to launch the new drug development laboratories

    Russian pharmaceutical company NovaMedica launches R&D laboratories as part of its Technology Center project for the development and pilot production of innovative drugs. The facilities are designed to address the most challenging scientific tasks based on the state-of-the-art platforms incorporating nanotechnologies. The project investment totals $15m.                                                   

  • 03 October 2016

    Four NovaMedica Executives are in the Top-1000 Russian Managers Rating Released by the Managers Association of Russia and Kommersant Publishing House

    Four NovaMedica Executives are in the Top-1000 Russian Managers Rating Released by the Managers Association of Russia and Kommersant Publishing House

    Four NovaMedica executives are among the business leaders listed in the Top-1000 Russian Managers rating released annually by the Managers Association of Russia and Kommersant Publishing House.

  • 13 July 2016

    Photo: Pfizer and NovaMedica announce a strategic partnership in Russia

    Photo: Pfizer and NovaMedica announce a strategic partnership in Russia

    Pfizer, one of the world’s premier biopharmaceutical companies and NovaMedica, a Russian pharmaceutical company established by Rusnano and Domain Associates, have entered into an agreement to cooperate, signalling the development of a new partnership. Through this partnership, Pfizer proposes to invest in NovaMedica’s construction of a new manufacturing plant in the Kaluga region and license the technology for production of more than 30 medicinal products from its portfolio to the Russian partner.

  • 13 July 2016

    Pfizer and NovaMedica announce a strategic partnership in Russia

    Pfizer and NovaMedica announce a strategic partnership in Russia

    Pfizer, one of the world’s premier biopharmaceutical companies and NovaMedica, a Russian pharmaceutical company established by Rusnano and Domain Associates, have announced the start of a long-term strategic partnership to locally manufacture and bring to the Russian market a number of important medicines. The first step will be the construction of a modern pharmaceutical manufacturing plant located in the Vorsino industrial park, Kaluga Region. 

  • 25 June 2015

    RMI Partners reinforcing the team

    RMI Partners reinforcing the team

    June 25, Moscow – Today, RMI Partners, a venture capital management company investing in research and development of innovative biopharmaceutical products, has informed that its management team had been reinforced with a new Managing Director Alexander Kuzin.

  • 22 June 2015

    Leonid Melamed: uncertainty period is the best time to make important tactical and strategical decisions

    Leonid Melamed: uncertainty period is the best time to make important tactical and strategical decisions

    June 25, 2015, Vedomosti newspaper office will host a FocusForum Conference in Moscow with a leading participation of Leonid Melamed, the Chairman of Team Drive, member of the Board of Directors of NovaMedica, RMI Partners and Doctor Ryadom. The conference’s goal is to gather experts and share ideas and valuable experience in the time of business challenges. In his video interview to Vedomosti, Leonid explained his vision of the company management tasks in the period of uncertainty. 

  • 18 June 2015

    NovaMedica is planning to create around 15 innovative nanotech-involved pharmaceutical products

    NovaMedica is planning to create around 15 innovative nanotech-involved pharmaceutical products

    A Russian pharmaceutical company NovaMedica is planning to grow its R&D activities targeted at building a portfolio of proprietary nanotech-involving pharmaceutical products. This is what has been announced today by Vladimir Gurdus, General Manager at RMI Partners, managing company of NovaMedicw, at the Annual Saint Petersburg International Economic Forum during his panel discussion titled “Nanotechnologies – meeting the expectations?”

All Partners

All Portfolio

MEDIA CENTER

  • Pfizer and NovaMedica Complete Strategic Partnership Agreement for the Technology Transfer of 30 Key Medicines

    Pfizer and NovaMedica Complete Strategic Partnership Agreement for the Technology Transfer of 30 Key Medicines

    Pfizer Inc, one of the world’s premier biopharmaceutical companies and NovaMedica, a Russian pharmaceutical company established by Rusnano and Domain Associates, have completed the last stage of negotiations for a long-term strategic partnership designed to transfer the rights and technologies for the production of more than 30 life-saving and essential drugs from the Pfizer product portfolio. The deal will enable Pfizer and NovaMedica to improve the health of patients in Russia and modernize the Russian pharmaceutical industry.

All news